Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Califf Touches On A Range Of Issues And Priorities During Fireside Chat

Executive Summary

During a recent webinar hosted by the Alliance for a Stronger FDA, commissioner Robert Califf discussed the agency’s 2024 budget, its ongoing reorganization, AI, LDTs, and the continuing problem of misinformation.

You may also be interested in...



Educating Congress Becomes More Essential For FDA With Key Capitol Hill Departures

Energy and Commerce Committee Chair Cathy McMorris Rodgers’ decision not to seek reelection may mean FDA officials must orient a new chair on their activities and priorities.

Identifying Optimal Use Cases For Generative AI In Health Care: DHIS West Panelists Share Views

Gen AI has enabled insurance provider Elevance Health to reduce the time needed for processing health system rosters from an average of 90 days to an hour, according to Ashok Chennuru, global chief data and insights officer at Elevance subsidiary Carelon Digital Platforms. Chennuru was one of four panelists at DHIS West to discuss gen AI’s present and future in health care.

US FDA’s Congressional Education Becoming More Essential With Key Member Departures

Energy and Commerce Committee Chair Cathy McMorris Rodgers’ decision not to seek reelection may mean FDA officials must orient a new chair on their activities and priorities.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT154390

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel